NCT01347853View on ClinicalTrials.gov

Safety and Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain

PHASE3CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2007

Conditions

Postoperative Pain

Interventions

DRUG

Ketorolac tromethamine

30 mg intranasal post-surgery for up to 5 days total

DRUG

Placebo

Intranasal post-surgery for up to 5 days total

Trial Locations (1)

Unknown

Waikato Clinical Research, Hamilton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Egalet Ltd

INDUSTRY